Adams Looks To Mucinex Extensions; “Mr. Mucus” Marries
This article was originally published in The Tan Sheet
Executive Summary
Adams Respiratory Therapeutics sees additions to its Mucinex extended-release guaifenesin line as "key" to the firm's long-term growth strategy